Funder
U.S. President’s Emergency Plan for AIDS Relief
National Institute of Allergy and Infectious Diseases
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.
2. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369(9562):643–56.
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.
4. World Health Organization. Voluntary medical male circumcision for HIV prevention in 14 Priority Countries In Eastern And Southern Africa: July 2017 Progress Brief. Accessed online Feb 2, 2017 at
http://www.who.int/hiv/pub/malecircumcision/vmmc-progress-brief-2017/en/
.
5. Morris BJ, Wamai RG. Biological basis for the protective effect conferred by male circumcision against HIV infection. Int J STD AIDS. 2012;23(3):153–9.
https://doi.org/10.1258/ijsa.2011.011228
.